Major Shareholding Notification • Nov 7, 2025
Major Shareholding Notification
Open in ViewerOpens in native device viewer
Pursuant to Section 30 of the Danish Capital Markets Act, Novonesis hereby announces that BlackRock, Inc. has notified Novonesis of the following status relating to the position of share capital attached to shares and share capital through financial instruments.
Per November 5, 2025, BlackRock, Inc. has adjusted its holding in Novonesis and now holds below 5% of total share capital attached to shares including share capital held through financial instruments (previously combined 5.23%).
November 7, 2025 Company announcement No. 47
Tobias Bjorklund +45 3077 8682 [email protected]
Anders Enevoldsen +45 5350 1453 [email protected]
Katrine Spedtsberg Poulsen [email protected]
Novonesis is a global leading biosolutions company transforming the way we all produce, consume and live. In more than 30 industries our biosolutions are helping companies meet their business needs and the needs of our planet. Our 10,000 people worldwide work closely with our partners and customers to challenge conventional thinking and transform business with biology.
CVR number: 10 00 71 27 – LEI: 529900T6WNZXD2R3JW38
Novozymes A/S, part of Novonesis Group Krogshoejvej 36 2880 Bagsvaerd Denmark
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.